Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCL) is an electrolyte replacement product used to treat or prevent hypokalemia. It is available in oral and intravenous formulations.
## Primary Indications
* Treatment and prevention of hypokalemia.
## Adult Dosing
Dosing is highly individualized based on serum potassium levels and clinical status.
* **Oral Replacement:**
* **Prevention:** Typically 20 mEq (1000 mg) per day, divided into 1-2 doses.
* **Treatment:** 40-100 mEq (2000-5000 mg) per day, divided into 4-5 doses. Maximum daily dose usually capped at 100-120 mEq (5000-6000 mg) without strict electrolyte monitoring.
* **Intravenous (IV) Replacement:**
* **General Treatment:** Typically administered at a rate not exceeding 10-20 mEq/hour. Concentrations should generally not exceed 40 mEq/L in peripheral lines, and 60 mEq/L in central lines, unless in a critical care setting with continuous cardiac monitoring.
* **Maximum Rate:** Do not exceed 20 mEq/hour in most patients due to risk of cardiac arrhythmias. Higher rates (up to 40 mEq/hour) may be used in severe, life-threatening hypokalemia with continuous ECG monitoring, but this is often reserved for specific protocols.
* **Maximum Single Dose:** Generally not to exceed 40 mEq in peripheral IV lines. Total daily dose depends on severity and clinical status.
## Pediatric Dosing
Dosing is individualized and often calculated based on weight and serum potassium levels.
* **Oral Replacement:**
* Recommended daily allowance varies by age. For replacement, doses often range from 1-5 mEq/kg/day, divided into multiple doses, not to exceed 100 mEq/day.
* **Intravenous (IV) Replacement:**
* **General Treatment:** Rates usually do not exceed 0.3-0.5 mEq/kg/hour. Total daily dose typically 1-3 mEq/kg/day.
* **Maximum Concentration:** Usually 40 mEq/L.
* **Maximum Rate:** 0.5 mEq/kg/hour in most pediatric patients. Higher rates require cardiac monitoring and specific protocols.
## Dose Adjustments
* **Renal Impairment:** Dose reduction is necessary. Monitor serum potassium closely, as impaired renal function can lead to hyperkalemia.
* **Adrenal Insufficiency:** May require lower doses or alternative management.
## Contraindications
* Hyperkalemia.
* Conditions which may cause hyperkalemia, such as severe renal impairment, untreated Addison's disease, anuria, and oliguria.
* Certain medications (e.g., potassium-sparing diuretics, ACE inhibitors, ARBs) used concurrently can increase the risk of hyperkalemia.
## Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, abdominal pain (oral).
* **Serious:** Hyperkalemia (symptoms include muscle weakness, paresthesias, fatigue, arrhythmias, cardiac arrest), phlebitis or venous irritation (IV).
## Key Drug Interactions
* **Potassium-sparing diuretics (e.g., spironolactone, amiloride), ACE inhibitors (e.g., lisinopril), ARBs (e.g., losartan), NSAIDs:** Increase the risk of hyperkalemia.
* **Digoxin:** Hyperkalemia can increase digoxin toxicity. Hypokalemia can decrease it.
* **Diuretics (thiazide, loop):** Can increase potassium loss, potentially requiring potassium supplementation.
## Monitoring
* **Serum Potassium:** Frequent monitoring is essential, especially during IV administration and in patients with renal impairment. Frequency depends on clinical status and route of administration.
* **Renal Function:** Monitor BUN and serum creatinine.
* **ECG:** Monitor for signs of hyperkalemia (peaked T waves, prolonged QRS) especially with rapid IV infusion or in patients with risk factors.
* **Urine Output:** Ensure adequate urine flow.
## Clinical Pearls
* Oral potassium chloride formulations can be irritating to the gastrointestinal tract. Administer with food or fluids to minimize gastric distress.
* Liquid or effervescent formulations may be better tolerated than solid tablets.
* Rapid IV infusion of potassium chloride can be fatal. Administer slowly and cautiously, always with cardiac monitoring for rates exceeding 10-20 mEq/hour.
* Consider the total potassium load from all sources, including IV fluids and medications.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before administering any medication. Dosing and safety recommendations can change.